Mentari Therapeutics, Inc. Common Stock (MTRI) Stock Price

MTRIStock

$18.60−10.29%52W

Market Cap$1.08B

P/E—

PEG Ratio—

Div yield—

Beta1.09

MTRI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)137.13%

Price vs S&P 500 (4W)18.91%

VGM Score45.58

Book Value / Share (Quarterly)$0.20

P/TBV (Annual)4.78x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)65.55%

Cash Flow / Share (Quarterly)$-1.62

Price vs S&P 500 (YTD)35.83%

Gross Margin (TTM)35.87%

Net Profit Margin (TTM)-170.83%

EPS (TTM)$-2.88

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-2.88

EPS (Annual)$-8.36

ROI (Annual)-60.75%

Gross Margin (Annual)34.53%

Net Profit Margin (5Y Avg)-610.28%

Cash / Share (Quarterly)$0.42

Revenue Growth QoQ (YoY)-26.22%

ROA (Last FY)-52.39%

Revenue Growth TTM (YoY)-32.84%

EBITD / Share (TTM)$-2.49

ROE (5Y Avg)-110.61%

Operating Margin (TTM)-176.99%

Cash Flow / Share (Annual)$-1.62

P/B Ratio8.94x

P/B Ratio (Quarterly)4.78x

EV / Revenue (TTM)2.29x

Net Interest Coverage (TTM)-32.42x

ROA (TTM)-69.09%

EPS Incl Extra (Annual)$-8.36

Current Ratio (Annual)1.37x

Quick Ratio (Quarterly)1.25x

3-Month Avg Trading Volume0.07M

52-Week Price Return-10.29%

Tangible BV / Share (Quarterly)$0.20

P/S Ratio (Annual)1.95x

Asset Turnover (Annual)0.32x

52-Week High$23.30

Operating Margin (5Y Avg)-631.89%

EPS Excl Extra (Annual)$-8.36

Tangible BV CAGR (5Y)-29.82%

26-Week Price Return140.14%

Quick Ratio (Annual)1.25x

13-Week Price Return8.40%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)1.37x

Enterprise Value$7.42M

Asset Turnover (TTM)0.24x

Book Value / Share Growth (5Y)-78.72%

Inventory Turnover (Annual)2.94x

Pretax Margin (Annual)-165.14%

Cash / Share (Annual)$0.42

3-Month Return Std Dev106.02%

Gross Margin (5Y Avg)34.66%

ROE (Last FY)-60.75%

Net Interest Coverage (Annual)-5.98x

EPS Basic Excl Extra (Annual)$-8.36

P/FCF (TTM)3204.68x

Receivables Turnover (TTM)14.55x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-2.88

Receivables Turnover (Annual)12.08x

ROI (TTM)-82.01%

P/S Ratio (TTM)2.96x

Pretax Margin (5Y Avg)-610.19%

Revenue / Share (Annual)$5.06

Tangible BV / Share (Annual)$0.20

Price vs S&P 500 (52W)-21.54%

Year-to-Date Return47.25%

5-Day Price Return18.16%

EPS Normalized (Annual)$-8.36

ROA (5Y Avg)-84.68%

Net Profit Margin (Annual)-165.14%

Month-to-Date Return-2.44%

Cash Flow / Share (TTM)$-2.20

EBITD / Share (Annual)$-7.92

Operating Margin (Annual)-160.78%

ROI (5Y Avg)-110.61%

EPS Basic Excl Extra (TTM)$-2.88

P/TBV (Quarterly)4.78x

P/B Ratio (Annual)4.78x

Inventory Turnover (TTM)2.03x

Pretax Margin (TTM)-170.83%

Book Value / Share (Annual)$0.20

Price vs S&P 500 (13W)10.04%

Beta1.09x

P/FCF (Annual)94.91x

Revenue / Share (TTM)$0.82

ROE (TTM)-82.01%

52-Week Low$5.75

vGradeD

gGradeD

mGradeB

vgmGradeC

Industry Peers — Pharmaceuticals(576)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
MTRIMentari Therapeutics, Inc. Common Stock	D	D	B	3.0x	-32.8%	35.9%	—	$18.60
LLYEli Lilly & Co.	F	B	A	15.5x	45.5%	83.6%	27.6%	$1446.39
JNJJohnson & Johnson	D	C	B	7.0x	7.8%	67.7%	14.9%	$286.77
ABBVABBVIE INC.	D	B	B	7.9x	10.7%	73.7%	-2.9%	$295.44
MRKMerck & Co., Inc.	D	C	B	5.4x	4.9%	76.6%	21.2%	$147.71
NVSNovartis AG	C	C	B	5.1x	2.3%	75.2%	15.3%	$160.57
AZNAstraZeneca PLC	D	B	B	4.6x	7.3%	81.7%	21.9%	$185.10
ABTAbbott Laboratories	C	C	B	3.9x	10.0%	57.1%	8.2%	$108.64
NVONovo-Nordisk A/S	B	C	C	3.7x	5.6%	80.7%	20.7%	$41.62
PFEPfizer Inc.	C	D	B	2.6x	1.3%	74.9%	-3.5%	$28.86
VRTXVertex Pharmaceuticals Inc	D	C	B	10.4x	10.5%	85.6%	8.3%	$540.64
BMYBristol-Myers Squibb Co.	C	C	B	2.5x	4.2%	70.5%	—	$63.72
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.6x	13.4%	73.6%	-8.2%	$48.45
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	B	2.3x	4.3%	73.8%	-0.5%	$50.60
REGNRegeneron Pharmaceuticals Inc	D	B	A	5.8x	18.6%	86.8%	6.3%	$960.82
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	D	B	2.3x	6.3%	65.8%	-12.6%	$21.50
TEVATeva Pharmaceutical Industries Limited	D	D	A	3.0x	2.7%	53.6%	—	$44.26
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	7.4x	31.1%	88.5%	—	$416.12
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	15.2x	11.4%	—	-12.1%	$69.16
ZTSZOETIS INC.	C	C	B	3.4x	1.4%	71.6%	12.0%	$83.73
GMABGenmab A/S ADS	D	C	A	7.5x	22.3%	93.0%	6.8%	$51.40
ROIVRoivant Sciences Ltd. Common Shares	D	F	A	3802.7x	-67.6%	81.2%	—	$39.37
INSMInsmed, Inc.	F	A	B	17.0x	240.0%	84.4%	—	$121.30
UTHRUnited Therapeutics Corp	C	C	B	7.6x	1.9%	86.3%	19.3%	$597.43
VTRSViatris Inc. Common Stock	B	C	A	1.6x	4.3%	41.1%	—	$20.84
ALNYAlnylam Pharmaceuticals, Inc.	C	A	D	4.2x	56.2%	77.3%	—	$164.72
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	14.4x	113.3%	91.3%	—	$276.02
JAZZJazz Pharmaceuticals, Inc.	C	C	B	3.2x	13.5%	89.1%	-1.4%	$242.90
BBIOBridgeBio Pharma, Inc. Common Stock	D	A	B	16.1x	167.3%	94.3%	—	$78.45
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.7x	11.9%	55.4%	29.9%	$26.85
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.5x	-3.5%	61.1%	16.5%	$14.82
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	11837.5x	—	—	—	$14.25
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.0x	18.1%	79.2%	-17.0%	$57.37
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	7940.4x	—	—	—	$103.84
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	6.9x	92.8%	91.0%	—	$423.54
TGTXTG Therapeutics, Inc.	D	B	A	12.2x	76.1%	82.4%	—	$64.40
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	1072.3x	—	—	—	$327.54
PTGXProtagonist Therapeutics, Inc	F	B	B	30.7x	34.8%	—	—	$131.28
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	A	B	27.2x	61.0%	72.8%	—	$115.67
CORTCorcept Therapeutics Inc.	D	B	C	8.1x	30.0%	98.5%	-0.5%	$73.12
ALKSAlkermes Inc. plc	D	C	B	4.5x	15.3%	82.9%	—	$47.26
CYTKCytokinetics Inc.	F	B	C	69.2x	29.9%	—	—	$56.22
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$87.50
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	A	A	8.0x	58.2%	90.2%	—	$96.02
AXSMAxsome Therapeutics, Inc	D	B	C	8.5x	54.2%	93.3%	—	$142.35
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.3x	8.9%	40.2%	-18.4%	$21.41
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	152.0x	—	—	—	$106.71
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$166.90
ARWRArrowhead Research Corporation	D	A	D	14.8x	-45.6%	95.2%	—	$47.45
LGNDLigand Pharmaceuticals Inc.	F	C	A	24.9x	1.0%	95.2%	—	$310.65
MIRMMirum Pharmaceuticals, Inc. Common Stock	F	B	B	9.0x	42.2%	81.7%	—	$93.03

MTRI Insider Transactions

BuyOct 23, 2026
ADAR1 CAPITAL MANAGEMENT LLC
Beneficial Owner of more than 10% of a Class of Security
Shares: 4Value: $5
BuyOct 19, 2026
ADAR1 CAPITAL MANAGEMENT LLC
Beneficial Owner of more than 10% of a Class of Security
Shares: 1,087Value: $1,435
BuyOct 8, 2026
ADAR1 CAPITAL MANAGEMENT LLC
Beneficial Owner of more than 10% of a Class of Security
Shares: 10,903Value: $14,484
BuyOct 5, 2026
ADAR1 CAPITAL MANAGEMENT LLC
Beneficial Owner of more than 10% of a Class of Security
Shares: 42,920Value: $57,080
BuySep 16, 2026
ADAR1 CAPITAL MANAGEMENT LLC
Beneficial Owner of more than 10% of a Class of Security
Shares: 91,101Value: $118,076

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for October 2026

Companies in Related Industries

INBXInhibrx Biosciences, Inc. Common StockBiological Products
VORVor Biopharma Inc. Common StockBiological Products
UANCVR Partners, LPAgricultural Chemicals
ECVTEcovyst Inc.Chemicals
IMTXImmatics N.V. Ordinary SharesBiological Products
KROKronos Worldwide, Inc.Industrial Chemicals
GPREGreen Plains, Inc.Industrial Chemicals
FTKFlotek Industries, Inc.Industrial Chemicals

Same SIC sector, outside this company's own industry.

52-Week Range

Low$5.75

High$23.30